Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01668069 · ClinicalTrials.gov registry record · NA
Ondansetron VS Doxylamine and Pyridoxine in Treating Nausea of Pregnancy
A NA study, sponsored by United States Naval Medical Center, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT01668069 is a NA study that has completed, run by United States Naval Medical Center, San Diego. The registered enrollment target is 36 participants.
The verdict
NCT01668069, a NA study, has completed, sponsored by United States Naval Medical Center, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
Our purpose is to determine whether ondansetron, a commonly used antiemetic, is equivalent in efficacy to the combination of pyridoxine and doxylamine, the currently recommended first line therapy for nausea and vomiting in pregnancy by the American Congress of Obstetricians and Gynecologists (ACOG). Since both treatments are safe in pregnancy, many physicians are using ondansetron as first line in practice. Despite this practice and the recommendations from ACOG, there is not data to suggest that ether practice is superior. This will be the first prospective, randomized, double blind, controlled trial comparing the two treatments. We hypothesize that ondansetron will be equally efficacious in reducing nausea and episodes of emesis. By alleviating nausea and vomiting associated with pregnancy, patients will likely benefit from less Emergency Department visits, urgent clinic visits, and admissions for progression to hyperemesis gravidarum.
Interventions
- DRUG Ondansetron
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2012-10 |
| Est. Completion | 2013-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01668069
The ClinicalTrials.gov registry entry for NCT01668069 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is United States Naval Medical Center, San Diego, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ondansetron is the first listed.
NCT01668069 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01668069 about?
NCT01668069 is a clinical study titled "Ondansetron VS Doxylamine and Pyridoxine in Treating Nausea of Pregnancy". Our purpose is to determine whether ondansetron, a commonly used antiemetic, is equivalent in efficacy to the combination of pyridoxine and doxylamine, the currently recommended first line therapy for nausea and vomiting in pregnancy by the American Congress of Obstetricians and Gynecologists (ACOG)...
What is the current status of trial NCT01668069?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2012-10. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01668069?
The interventions under investigation include: Ondansetron (DRUG).
Who is sponsoring clinical trial NCT01668069?
This trial is sponsored by United States Naval Medical Center, San Diego, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.